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The N eem Tree Patent: International 
Conflict over the Commodification of Life 
Emily Marden* 
INTRODUCTION 
Biotechnology' has revolutionized the pace of innovation in the life 
sciences by allowing scientists efficient means of isolating and altering 
individual traits. For example, in agriculture, innovators have pro-
duced plants custom-designed for resistance to specific pests, bacteria 
altered to bypass growth-limiting natural soil cycles, and natural pesti-
cides created to compete against the more toxic synthesized ones.2 
Scientists even claim to have formulated a tree with a higher cellu-
lose content which will make future paper production more efficient. 
Biotechnology has had similarly spectacular effects in the pharmaceu-
tical industry. There, researchers have already produced a raft of new 
drugs, promising to treat everything from cancer to hypertension.3 
In large part, this wave of innovation has been fueled by material 
gathered from biologically diverse regions of the globe in a process 
generally known as "bio-prospecting." Bio-prospectors are the modern 
incarnation of earlier prospectors: they travel to "untapped" geo-
graphical regions with the aim of amassing either local knowledge of 
useful biological applications or genetic samples from plants, animals, 
* Associate, Sidley & Austin, Washington, D.C. A.B., Biology, Harvard University; M.Phi!., 
History and Philosophy of Science, Cambridge University; A.M., History of Science, Harvard 
University;J.D., New York University. The author would like to thank Roger A. Frie for his critical 
insight and support in the writing of this article. 
I "Biotechnology" is not an easy term to define even for experts working within the industry. 
The Convention on Biological Diversity ("CBD") defines it as "any technological application that 
uses biological systems, living organisms, or derivatives thereof, to make or modi/)' products or 
processes for specific use." Convention on Biological Diversity,June 5,1992, art. 2, 311.L.M. 818, 
823 [hereinafter CBDJ. Following this usage, I am using the term herein to include any innova-
tion that uses biological knowledge as its starting point. I realize that this usage is broader than 
common American usage which refers solely to practices using recombinant DNA techniques. 
2 See SHELDON KRIMSKY & ROGER P. WRUBEL, AGRICULTURAL BIOTECHNOLOGY AND THE ENVI-
RONMENT 167-68 (1996); see also Don't Eat YOUT Veggies, GRASS ROOTS & PUB. POL'y (FOUND. ON 
ECON. TRENDS), Fall 1995, at 8; Michael Pollan, Playing God, N.V. TIMES, Oct. 25, 1998. 
3 See generally Curtis M. Horton, Protecting Biodiversity and Cultuml Diversity Under Intellectual 
Property Law: Toward a New International System, 10 J. ENVTL. L. & LITIG. 1 (1995). 
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and humans for later use in product research and development. By 
availing themselves of this wide spectrum of material, innovators gain 
an invaluable source of material and product possibilities.4 Thus far, 
this practice has been enormously productive for American industry. 
At present, biotechnology is one of the fastest growing industries in 
the world with total product sales for the United States biotechnology 
industry of approximately $4 billion in 1991, and a promise, by one 
estimate, of at least $50 billion in sales in the year 2000.5 No one doubts 
that access to the world's biodiversity is important for the industry's 
continued development. 
At the same time, there are grave concerns about the manner in 
which biological resources are being appropriated from these biologi-
cally diverse-and generally "developing"-countries. The uncompen-
sated "harvesting" of biological resources from developing states can 
be seen as an insidious new form of colonialism, since multinational 
companies reap huge benefits while none of the profits flow back to 
the states providing the resources.6 In this sense, some observers refer 
to the Western innovators as "pirates": they engage in an illegal and 
immoral operation of stealing indigenous knowledge and genes with 
the ultimate aim of making themselves richer while keeping the poorer 
nations poor.7 According to Van dana Shiva, one of the world's most 
prominent activists on this issue, this practice of plundering the devel-
oping world's natural resources has a long history. For her, biological 
"strip-mining" is simply a continuation of the British Empire's efforts 
to take India's riches while oppressing her subjects. She points out that 
the West also used the promise of a "better life" to dupe developing 
nations into consenting to increased dependence on the industrial 
world in the Green Revolution-a revolution which, she asserts, ulti-
mately resulted in more crop failure, poverty, and disease.8 
4 See, e.g., Peter J. Goss, Guiding the Hand that Feeds: Toward Socially Optimal Appropriability in 
Agricultural Biotechnology Innovation, 84 CAL. L. REV. 1395, 1400-03 (1996). 
5 SeeJ. Leslie Glick, The Industrial Impact of the Biological Revolution, in TECHNOLOGY AND THE 
FUTURE 364 (Albert H. Teich ed., 5th ed. 1990). 
6 This is a complaint shared by many leaders of developing countries. See Craig D. Jacoby & 
Charles Weiss, Recognizing Property Rights in Traditional Biocultural Contribution, 16 STAN. ENVTL. 
LJ. 74, 89-91 (1997). Activists also share this complaint. See generally VANDANA SHIVA, BIOPIRACY: 
THE PLUNDER OF NATURE AND KNOWLEDGE (1997) [hereinafter SHIVA, BIOPIRACyj; VANDANA 
SHIVA, MONO CULTURES OF THE MIND (1993) [hereinafter SHIVA, MONOCULTURESj. 
7 See SHIVA, BIOPIRACY, supra note 6, at 81-84. 
8 See generally VANDANA SHIVA, THE VIOLENCE OF THE GREEN REVOLUTION (1991). Therein, she 
argues that the Green Revolution, like British colonial practices, was "sold to" India (and other 
nations) as a vehicle for improving the lives of natives, and that in actuality it destroyed ecologi-
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Opposition to Western use of biological resources poses a very real 
threat to the continued development of the biotechnology industry. 
International law allows nations to prevent interference with property 
inside their borders.9 Thus, nations that are unhappy with the property 
rights protection given to genetic resources have several possible op-
tions. One approach would be to nullify intellectual property rights 
given to commercial products that were developed from appropriated 
genetic resources.]() Alternatively, a country could simply physically 
exclude researchers or corporations. 11 Depending on interpretation, 
the Convention on Biological Diversity ("CBD") appears to make these 
threats a real possibility. Article 15 of the CBD, for example, recognizes 
a limited sovereign property right in genetic material found within a 
nation's boundaries. 12 In addition, the CBD has been interpreted as 
requiring technology transfer to developing countries in exchange for 
the right to use biological resources. 13 Regardless of interpretation, 
many in the developing world are threatening to obstruct continued 
bio-prospecting until Western researchers and corporations make a 
fairer deal. To avoid these types of threats, it is in the best interest of 
the United States to understand what is at stake in international patent 
disputes and then to consider revising current practices. 
This paper attempts to take a first step in this process by examining 
the issues underlying a single recent dispute. My subject is the uproar 
that came about after a U.S. company obtained a patent on an extract 
of the neem tree, a culturally significant Indian resource. My aim is to 
look beyond the heated rhetoric surrounding the controversy in order 
to reach an understanding of what is actually at stake for the various 
parties. I will begin by looking first at the background and unfolding 
cally sound agricultural practices, introduced new-more dreadful-agricultural plagues, and 
made Indian fanners wholly dependent on Western seed companies. 
9 See U.N. CHARTER OF ECONOMIC RIGHTS AND DUTIES OF STATES art. 29. 
10 See Christopher D. Stone, lVhat to Do About Biodiversity: Property Rights, Public Goods, and 
the Earth's Biological Riches, 68 S. CAL. L. REv. 577, 601 (1995) (and following pages). 
11 See Richard Stone, Proposed Global NefworJl for Ecology Data Stirs Debate, SCIENCE, Nov. 18, 
1994, at 1155 ("[T)he African delegations [to the Biodiversity Convention) are expected to 
announce a temporary ban on commercial access to their biological resources until they and 
other countries can develop rules on 'fair and equitable sharing of benefits' .... "). This shutting 
of borders is of global concern as well because of the fear that biodiversity will continue to 
decrease and opportunities for beneficial projects will be lost forever. See, e.g., Vandana Date, 
Global ''Development'' and its Environmental Ramifications-the Interlinking of Ecologically Sustain-
able Development and Intellectual Property Rights, 27 GOLDEN GATE U. L. REV. 631, 633-36 (1997). 
12 See CBD, supra note 1, art. 5. 
13 See Date, supra note II, at 643-49. 
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of the controversy. Then, I will turn to its causes, in an effort to reach 
the heart of the dispute. 14 
A number of explanations have been offered in terms of other 
bio-prospecting disputes. Some have identified the problem behind 
such disputes as simply the lag in scientific ability between developed 
and developing countries. They claim that tensions will dissipate as 
these nations invest more money in science and revamp their patent 
processes so that they too produce valuable patents. 15 Others have 
located the cause in the unequal distribution of wealth and the failure 
by successful bio-prospectors to recognize source nations or groups as 
contributors to innovations. 16 Still others have maintained that contro-
versies are the natural outgrowth of an unfair system of international 
intellectual property rights, including those in the Agreement on 
Trade Related Aspects of In tellectual Property Righ ts ("TRIPS"). They 
argue that because these laws only recognize individual innovations 
which were "scientifically" achieved, the typically communal, "folk" 
knowledge of developing countries are excluded, leading to unrest. 
My analysis of the neem tree incident shows that all of these factors 
playa part. However, I also believe that at root the dispute is a philo-
sophical one over the morality and desirability of commodifying life. 
Thus, like Moore v. Regents of the University of California, the dispute 
pits a utilitarian approach to intellectual property law against a more 
holistic, essentialist one. 17 Thus, in the end, this controversy cannot be 
easily resolved simply by compensating India or by rewriting laws. 
Rather, any solution will have to involve not only economic considera-
tions, but also a serious discussion of closely held philosophical beliefs 
14 My assumption here is that the debate operates on both a substantive and a symbolic level. 
Following anthropologist Clifford Geertz and historian Richard Damton, I present the "mean-
ings" implicit in the discussion. For an extensive discussion of this theoretical approach, see 
generally ROBERT DARNTON, THE GREAT CAT MASSACRE (1985); CLIFFORD GEERTZ, THE INTER-
PRETATION OF CULTURES (1973). 
15 See Ashok Sharma, Tree Focuses Debate On Control of Resources, L.A. TIMES, Nov. 19, 1995, at 
A6. 
16 See, e.g., Sandy Tolan, Against the Grain: Multinational Carparations Peddling Patented Seed 
and Chemical Pesticides are Poised to Revolutionize India's Ancient Agricultural System. But at What 
Cost?, L.A. TIMES, July 10, 1994, at 18. This position largely underlies the CBD. Also, the 
Merck-INBIO agreement takes this as its fundamental presumption, with payment going to Costa 
Rica for use of natural resources. See The Merck-InBio Agreement (visited Mar. 19, 1999) 
<http://www.idrc.ca/books/725.differen.html> (discussing the agreement). It should be noted, 
however, that this agreement has not been universally embraced. See People, Plants, and Patents 
(visited Mar. 9, 1999) <http://www.idrc.ca/books/ differen.html> (discussing the agreement and 
perspective on it). 
17 See generally Moore v. Regents of the Univ. of Cal., 793 P.2d 479 (Cal. 1990). 
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and the role they should play in harmonizing international intellectual 
property law. 
I. THE NEEM TREE CONTROVERSY 
The neem tree, azadirachta indica, is known in Sanskrit as "sarva-roga 
nivarini" or "curer of all ailments."18 The tree is tightly interwoven with 
the fabric of Indian culture: in some regions, the new year begins with 
eating the tender shoots of the neem tree while in other areas, the tree 
is worshipped as sacred. 19 In addition, the tree has long been known 
as an amazing resource. Ordinary Indians use neem tree bark to clean 
their teeth.20 Neem-Ieafjuice is used to prevent psoriasis and other skin 
disorders and to control parasitic infections.21 Neem extract is applied 
as an antidote to malaria.22 Neem tree seeds are valued as a spermicide 
and an insecticide.23 Neem oil is currently even being tested as a female 
con traceptive. 24 
The West was alerted to the tree's wonders in 1959, when a German 
entomologist reported that neem trees were spared during a locust 
swarm that devoured all other foliage.25 Since then, researchers in 
India and elsewhere have identified azadirachtin, a powerful insecti-
cide that is not harmful to humans, as one of the seed's active sub-
stances. Long before any official discovery, farmers in India had been 
applying this knowledge. The usual practice was to break up the seeds, 
soak them in water or alcohol, and then use the resulting emulsion on 
crops. For the farmers, application of neem as a pesticide was only 
limited by the rapid degradation of the chemical solution.26 
In the early 1990s, a group of American researchers innovated on 
this knowledge and found a way to alter the active ingredient to create 
a storage-stable version of the extract.27 As a result, in June 1992 the 
18 See Lori Wolfgang, Patents on Native Technology Challenged, SCIENCE, Sept. 15, 1995, at 1506; 
see also SIR MONIER MONIER-WILLIAMS, A SANSKRIT-ENGLISH DICTIONARY 888 (1970). 
19 See SHIVA, BIOPIRACY, supra note 6, at 69. 
20 See Clair Wood, 'Miracle tree' Has Promise, BANGOR DAILY NEWS, Dec. 5, 1997, at AI; see also 
A Cure All! (visited Mar. 19, 1999) <http://www.ajtsc.com/neemtree>. 
21 See Marilitz Dizon, Panacea for a Hundred and One Ailments, Bus. DAILY, Jan. 13, 1997, at 
AI. 
22 See id. 
23 See id; see also A Cure All!, supra note 20. 
24 See Wood, supra note 20, at AI; A Cure All!, supra note 20. 
25 See Paul Hoversten, Legal Battle Takes Root over "Miracle Tree, "USA TODAY, Oct. 18, 1995, at 
8A. 
26 See Jacoby & Weiss, supra note 6, at 75-76. 
27 See U.s. Patent No. 5,124,349, available in LEXIS, Patent Library, All File. 
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United States Patent Office issued Patent No. 5,124,349 to W.R. Grace 
& Co. ("Grace"), an agricultural chemical company based in Boca 
Raton, Florida, on this particular derivative of the neem tree. 28 The 
Grace patent covers both a method of creating a stabilized azadirachtin 
in solution and the stabilized azadirachtin solution itself,29 processes 
which make the extract both more valuable to the pesticide industry 
and more useful to farmers. 3o In March 1994, the Environmental Pro-
tection Agency registered Neemix, Grace's stabilized azadirachtin so-
lution, for use on food crops. Neemix is the first product derived from 
the neem tree approved for such use in the United States. 3! 
On its face, the Grace patent appears to be an unexceptional exam-
ple of American discovery, innovation, and commercialization. Accord-
ing to U.S. law, purification or modification of a naturally occurring 
compound can result in the award of a patent with claims to the 
purified substance.32 Further, the Grace patent appears to satisfy 35 
U.S.c. sections 101, 102, and 103 requirements that the invention 
(l) has some practical usefulness, (2) is novel in relation to the "prior 
art," (3) is not obvious from the "prior art" to a person of ordinary 
skill in the art at the time the invention was made, and (4) provides a 
description that is adequate to enable a knowledgeable person to 
practice the invention in the best mode.33 The fact that some contend 
that the improvement was "obvious" in India to Indian farmers does 
not itself defeat patentability in the United States.34 As it stands, section 
102(a) and (b) provide that foreign knowledge can only defeat a U.S. 
patent's novelty claim if that foreign knowledge appeared in a printed 
publication before the invention or application by the U.S. applicant.35 
28 See id. 
29 See id. 
30 See Richard H. Kjeldgaard & David R. Marsh, A Biotech Battle Brewing, LEGAL TIMES, Dec. 
11, 1995, at 16. 
31 See John F. Burns, Tradition in India vs. a Patent in the United States, N.Y. TIMES, Sept. 15, 
1995, at 04; Wolfgang, supra note 18, at 269. 
32 See, e.g., In re Kratz, 592 F.2d 1169 (C.C.P.A. 1979) (compound purified from strawberries 
can receive a patent even though that compound existed, in a non-purified form, in strawberries); 
see also Diamond v. Chakrabarty, 447 U.S. 303 (1980). 
3335 U.S.C. §§ 101-103 (1997). 
34 See Shayana Kadidal, Subject-Matter Imperialism? BiodiveTSity, FOf'eign PriOf' Art and the Neem 
Patent Controversy, 37 IDEA 371, 373 (1997) ("Vandana Shiva, one of many activists opposing 
Grace's patent ... [claims that] 'novelty exists mainly in the context of the ignorance of the 
West."'). 
35 35 U.S.C. § 102. For a very good analysis of the effect of these provisions on the neem 
controversy, see generally Kadidal, supra note 34. 
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Further, it is not clear that the Grace patent will have any actual 
economic or social effect in India. Indian farmers continue to be free 
to use their own neem extractions in whatever manner they desire, and 
Indian patent law historically has forbidden ownership of agricultural 
and medicinal products.36 Even more, Grace claims that the company 
will not seek an analogous patent in India, even post-TRIPS implemen-
tation, because the Indian patent process operates too slowly to make 
it usefulY In any case, it is doubtful that India will implement so-called 
"pipeline" protection, which would extend patent status to products 
already under patent elsewhere when their subject matter first becomes 
available in India. Pipeline protection is explicitly not required under 
TRIPS for applications preceding the entry-into-force, though it is 
required for subsequent applications. 38 Also, the argument has been 
made that the Grace patent may actually benefit Indian farmers. Grace 
is processing its seeds in India, and therefore in addition to harvesting 
neem for personal use, Indian farmers may gain the opportunity to sell 
the product to processors.39 Neem may become India's new cash crop. 
Nonetheless, to activists around the world, the Grace patent has 
become a rallying point against the Western imperial appropriation of 
developing countries' biological knowledge and resources. 40 Among 
other complaints, activists contend that the W.R. Grace patent is illegal 
because it fails to recognize Indian knowledge and therefore is not 
novel.41 In this sense, they view the patent as an example of how those 
"who have the muscle power ... will snatch whatever [they] can."42 
They also object to the neem patent on moral grounds, complaining 
that the plant is sacred and that the patent is therefore a "violation of 
36 See Group Challenges WR. Grace Pesticide Patent, REuT. Bus. REP., Sept. 13, 1995, available in 
LEXIS, News library, Reubus file. 
37 See Grace Issues Statement about Patent Jor Neem Pesticide, UNIVERSAL NEWS SERVICES, Sept. 
15, 1995, available in LEXIS, News Library, Wires File. 
38 See General Agreement on Tariffs and Trade: Multilateral Trade Negotiations Final Act 
Embodying the Result of the Uruguay Round of Multilateral Trade Negotiations. Apr. 15, 1994, 
Annex Ie: Agreement on Trade-Related Aspects of Intellectual Property Rights, art. 70.1, 70.8, 
33 I.L.M. 1197. Without pipeline protection, Grace's U.S. patent would presumably constitute 
prior art for a parallel Indian application, even if it was not found per se obvious in light of prior 
use or knowledge within India. 
39 See Kathleen R. Terry & Warren D. Woessner, Bring Them Back Alive! Patents on 'Products oj 
Nature, , (visited Mar. 19, 1999), <http://'.vww.slwk.com/paper9.html>; see also Wolfgang, supra 
note 18, at 1506. 
40 See Burns, supra note 31, at D4. 
41 See Wolfgang, supra note 18, at 1506. See also Group Challenges WR Grace Pesticide Patent, 
supra note 36. 
42 Burns, mpra note 31, at D4, quoting Dr. Vaidya Satyaa Pal, an Indian physician. 
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[Indian] identity."43 Ultimately, in September 1995, a coalition of 225 
agricultural, scientific, and trade groups as well as over 100,000 indi-
vidual Indian farmers, led by the organization the Foundation on 
Economic Trends, filed a legal petition with the U.S. Patent and Trade-
mark office. The petition argued that the patent should be revoked on 
grounds that it lacked novelty, and in addition, was immora1.44 The 
coalition vowed that it would make the W.R. Grace patent a watershed 
in international intellectual property disputes, in which it would con-
vince the world that the West was guilty of rampant intellectual piracy.45 
II. ANALYSIS 
A. Economic and Legal Concerns 
Lurking behind the neem dispute is a sense of anger and fear at the 
power of multinational corporations to transform India. In India, ac-
tivists commonly portray the multinational corporations as an evil force 
destroying the delicate fabric of Indian life. 46 Grace is thus invoked as 
the pillager of a beloved Indian tradition and the destroyer of Indian 
farmers' agricultural rights.47 In this sense, it is important to recognize 
that the battle over the Grace patent is in part the latest installment of 
a longer effort to thwart the development process from transforming 
India into just another industrialized economy modeled on the West. 48 
This sentiment is evident throughout bio-prospecting discussions: 
43 Sinikka Tarvainen, Indigen(JUs Peoples Protest Against "Biocolonialism," DEUTSCHE PRESSE-
ACENTUR, Nov. 29, 1997, available in LEXIS, World Library, Allnws file; see also Burns, supra note 
31, at D4, quoting Jeremy Rifkin ("What many Americans have not realized is ... the angel; 
frustration, and resentment in the developing countries against what they regard as piracy of 
their heritage .... "). 
44 See Burns, supra note 31, at D4; see also Kurt Kleiner, Pesticide Tree Ends Up in Court, NEW 
SCIENTIST, Sept. 16, 1995, at 7; Michael D. Lemonick, Seeds of Conflict: Critics Say a U.S. Company's 
Patent on a Pesticide from an Indian Tree is "Genetic Colonialism," TIME, Sept. 25, 1995, at 50. 
45 See Burns, supra note 31, at D4. 
46 See Bioprospecting/Biopiracy and Indigenous Peoples, RURAL ADVANCEMENT FOUND. INT'L 
(RAFI) COMMUNIQUE, Nov./Dec. 1997 (visited Mar. 22, 1999) available in <http://www.latin-
synergy.org/bioprospecting.html>. See also SHIVA, BIOPIRACY, supra note 6, at 81 (specifically 
accusing transnational corporations of hijacking the TRIPS agreement to their own ends). 
47 See, e.g., Tarvainen, supra note 43; Wolfgang, supra note 18, at 1506; Gr(JUP Challenges WR 
Grace Pesticide Patent, supra note 36. This perspective is also vividly illustrated by the violent 
demonstrations against the GATT that took place in India. In one incident, activists stormed into 
Cargill's Indian headquarters, destroyed seed stocks, and burned corporate records, all in an 
effort to stop the corporation from manipulating India into further agricultural dependence. See 
Tolan, supra note 16, at 18. 
48 See John F. Burns, Ancient Hindu Festival Thrives in Computer-Age India, N.Y. TIMES, Apr. 16, 
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Development is a beautiful word, suggesting evolution from 
within .... But the ideology of development has implied the 
globalization of the priorities, patterns, and prejudices of the 
West. Instead of being self-generated, development is im-
posed. Instead of coming from within, it is externally guided. 
Instead of contributing to the maintenance of diversity, devel-
opment has created homogeneity .... 49 
287 
For many, the neem tree controversy is more specifically about the 
inequitable distribution of Grace's economic gain: For many activists, 
it is inconceivable that those who merely "tinkered" with neem seeds 
should retain all economic benefit. They maintain that Indians pro-
vided the raw material-an assiduously cultivated understanding of the 
neem tree's properties-and that therefore they are the rightful ben-
eficiaries of any commercial development.5o Indeed, there is a substan-
tial amount of money at stake in these types of disputes. One report 
estimates that the developing world would gain $5.4 billion per year if 
multinational food, seed, and pharmaceutical firms paid royalties for 
local knowledge and plant varieties.51 Examples of one-way flow are 
numerous. For example, the native Indian plant rauwoljina serpentina 
provides raw material for a hypertension drug with $260 million in U.S. 
sales annually, yet none of the profits flows back to India.52 
Concerns about this economic phenomenon are widely shared. In-
dian activist Vandana Shiva maintains that the economic inequality be-
tween the affluent industrialized countries and the poor Third World 
ones was produced by 500 years of colonialism and the continued 
creation of mechanisms for draining wealth out of the Third World. 
Moreover, she accuses the industrialized world of using contemporary 
intellectual property regimes to further this kind of exploitation.53 For 
Shiva and others, India stands only to lose when multinational corpo-
rations come seeking short-term monetary gain.54 Similarly, at the 
1998, at AI0. For example, millions of Indians celebrate the ancient tradition of the mela despite 
India's entrance into the computer age. See id. 
49 SHlVA, BIOPIRACY, supra note 6, at 107. 
50 See id. at 69. 
51 See SEEDS AND SOVEREIGNTY (J. Kloppenburg ed., 1988); Office of Technology Assessment, 
Biotechnology in a Global Economy, OTA-BA-494 (1991). 
52 See KS. Jayaraman, India Set to End Gene Robbery, NATURE, Aug. 25, 1994, at 587. 
53 See SHIVA, BIOPIRACY, supra note 6, at 11-16. See generally SUSAN K SELL, POWER AND IDEAS: 
NORTH-SOUTH POLITICS OF INTELLECTUAL PROPERTY AND ANTITRUST (1998) (describing how 
this mistrust has histOl'ically led India to resist Western intellectual property regimes in general). 
54 See SHIVA, BIOPIRACY, supra note 6, at 11-16. See generally NICANOR PERLAS, OVERCOMING 
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United Nations Conference on the Environment and Development in 
Brazil ("Earth Summit"), President Ali Hassan Mwinyi of Tanzania 
revealed his own fears: 
[M] ost of us in developing countries find it difficult to accept 
the notion that biodiversity should flow freely to industrial 
countries while the flow of biological products from the in-
dustrial countries is patented, expensive and considered the 
private property of the firms that produce them. This asym-
metry reflects the inequality of opportunity and is unjust. 55 
Others argue that the neem patent exemplifies how unfair interna-
tional intellectual property regimes are to communal or traditional 
forms of knowledge. They contend that because intellectual property 
regimes have no mechanism for providing intellectual property pro-
tection to cultural or communal knowledge, that knowledge is suscep-
tible to theft. As Professor Naomi Roht-Arriaza, a scholar of interna-
tionallaw, explains, the fundamental presumptions of most intellectual 
property regimes exclude indigenous and local knowledge and thus 
allow injustices to take place: 
Most . . . local knowledge is collective and is passed down 
from generation to generation. It builds on prior knowledge 
in an organic, accretive way that makes it difficult to single 
out a certain individual inventor or inventive origin in time 
.... Indigenous and traditional communities that had no 
practical opportunity to participate in the development of 
world intellectual property systems and that are only now 
beginning to . . . demand a place in those systems . . . are 
frozen OUt.56 
Her analysis goes on to explain how the novelty, non-obviousness, and 
subject matter requirements of U.S. patent law a priori exclude recog-
nition of traditional or communal knowledge as knowledge capable of 
being protectedY Thus, for Roht-Arriaza, the laws determine that 
ILLUSIONS ABOUT BIOTECHNOLOGY (1994) (arguing that the spread of biotechnology is less about 
improving social and environmental problems and more about corporate profits). 
55 Jacoby & Weiss, supra note 6, at 89. 
56 Naomi Roht-Arriaza, Of Seeds and Shamans: The Appropriation of the Scientific and Technical 
Knowledge of Indigenous and Local Communities, 17 MICH. J. INT'L L. 919, 936-37 (1996). 
57 See id. at 936 (and following pages). It is interesting to note that this sense of exclusion from 
existing intellectual property regimes led to the incorporation of a number of vague local/na-
tional property rights provisions in the CBD. See CBD, supra note 1, art. 5. To many, the inclusion 
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innovations in communal cultures will always be regarded by the West 
as "obvious" knowledge and thus free for the taking. 58 Scholar Shayana 
Kadidal makes this contention real. She demonstrates that the section 
l02(a) and (b) foreign knowledge publication requirements have the 
effect of excluding most community-based knowledge in non-Western 
countries.59 Ultimately, Kadidal concludes that the foreign patent prior 
art requirements will defeat most "biodiversity patents" and that there-
fore, in the interest of international comity, they should be elimi-
nated.GO 
The petition for reexamination of Grace's patent explicitly makes 
this argument about neem.61 The petition maintains that neem's pes-
ticidal properties have been known in India for years, that communal 
cultures in India had already discovered storage-stable concoctions of 
the pesticide, and that Grace's patent is therefore obvious. 52 According 
to one Indian, the patent on neem extract makes about as much sense 
as patenting fire. 53 A press release issued by the Foundation on Eco-
nomic Trends supporting the petition argues that the format of the 
law demonstrates that Western intellectual property law is designed to 
keep traditional cultures in a subordinated, always impoverished posi-
tion.64 
In the wake of the neem tree controversy, Indian authorities are 
scrambling to make traditional Indian knowledge less available for easy 
appropriation by foreign companies by organizing repositories of local 
lore.55 In addition, there are renewed discussions within India of how 
the nation might reorder national patent protection to assure that 
of this biological resources debate in the CBD derailed the treaty from its primary object. See Kal 
Raustiala & David G. Victor, Biodiversi(v Since Rio, ENVIRONMENT, May 1996, at 31. 
58 See Roht-Arriaza, supra note 56, at 936-40. 
59 See Kadidal, supra note 34, at 373. 
60 See id. 
61 See Request for Reexamination of Patent No. 5,124,349, requested by the Foundation on 
Economic Trends, c/o Jeremy Rifkin, Reexamination No. 90/004050 (Off. Gaz. Pat. Office Jan. 
16,1996) Ex. Gp.:1205, allailable in LEXIS, Patent Library, All File [hereinafter Reexamination]. 
62 See id. 
63 See Burns, supra note 31, at D4. 
64 See More Than 200 Organizations From 35 Nations Mount Unprecedented Legal Challenge at 
the U.S. Patent and Trademark Office Against WR Grace Company, FOUND. ON ECON. TRENDS, 
Sept. 14, 1995. 
65 See Anil Agarwal & Sunita Narain, Pirates in the Garden of India, NEW SCIENTIST, Oct. 26, 
1996, at 14; see also A. Surya Prakash, India Patently Upset Over Threat to Ancient Remed)', ASIA 
TIMES, Aug. 6, 1996, at 6. 
290 BOSTON COLLEGE INTERNATIONAL & COMPARATIVE LAw REVIEW [Vol. XXII, No.2 
traditional and communal knowledge is granted national protection 
and thereby not drained from the country.ti6 
At the same time, the neem challenge is also motivated to some 
degree by common misperceptions about what the Grace patent actu-
ally means. Many of the participants in the debate appear to fear that 
a patent on an extract somehow confers a property right on the 
original entity itself.67 For example, anti-Grace activists publicly state 
that Grace's patent may have the insidious effect of forcing them to 
pay for the use of their own knowledge. 68 They speculate that instead 
of being able to make their own neem pesticide extracts, they will be 
forced to pay Grace for the processed analogue. They point to cur-
rently rising prices for the neem seedG9 and forecasts that prices will 
rise even higher.7u Further, they voice concern that while only three 
percent of the Indian neem seed harvest is purchased by Grace now, 
analysts have acknowledged that Grace's share eventually could be 
much greater.7l 
B. Commodification of Life 
Thus, on its face, the controversy over the Grace patent stems from 
a combination of political, economic and legal factors. At the same 
time, the controversy is also motivated by broader philosophical issues 
which· are more difficult to resolve. The neem dispute is at root an 
argument over whether patents on life, or living extracts, should exist 
at all. The American position on so-called life patents stems from 
utilitarian concerns about promoting a steady stream of innovation. 
Meanwhile, the position of the Grace challengers stems from an essen-
tialist view that life cannot and should not be owned. 72 The neem 
66 See Agarwal & Narain, supra note 65, at 14; India: Enviro Minister Calls for Neem Research 
Center, GREENWIRE, Jan. 11, 1996, available in LEXIS, News Library, Grnwre File (noting that 
"Environment and Forests Secretary N.R. Krishnan said the foremost question of today is how to 
prevent drain ofbiowealth from the country."). 
67This is noted by some observers of the debate. See electronic mail letter from Anil Gupta, 
Professor, Society for Research and Initiative for Sustainable Technologies and Institutions, to 
Institute for Agriculture and Trade Policy (Sept. 21, 1995) (on file with author). 
68 See, e.g., Sharma, supra note 15, at A6 (stating that "the products they create ... come back 
with a price tag."). 
69 See Lemonick, supra note 44, at 50. 
70 See Mara Bovsun, FET Challenges U.S. Patent on India's Natural Pesticide, BIOTECHNOLOGY 
NEWSWATCH, Sept. 18, 1995, available in LEXIS, News Library, Biotec File; Biodiversity: Groups 
Sue to Invalidate Pesticide Patent, GREENWIRE, Sept. 13, 1995, available in LEXIS, News Library, 
Grnwre File. 
71 See Grace Issues Statement about Patent for Neem Pesticide, supra note 37. 
72 The ownership of plants has generally been a less contentious issue. However, it is important 
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controversy must also be understood therefore, as an entry in the long, 
contentious debate over how patents and life should interact. 
The United States tends to adhere to a utilitarian, "fruits of one's 
labor" justification for patent protection of living things. 73 Indeed, the 
constitutional justification for patents-"to promote the progress of 
science and the useful arts"-is itself utilitarian. 74 This approach rea-
sons that promoting the creation of valuable intellectual innovations 
requires that companies and researchers be granted property rights in 
their creations. Without patent protection, the argument goes, ade-
quate incentives for creating the socially optimal output of innovations 
would not exist. Moreover, if competitors could simply use one an-
other's inventions, there would be no incentive for inventors to spend 
the vast amounts of time, energy, and money necessary to develop new 
products. In the United States, this approach has been applied to 
creations involving new variations on life forms,75 and, more recently, 
to "inventions" involving the extraction of some portion of living tis-
sue. 7G The Grace patent is in keeping with this approach. It rewards 
the company for expending the resources to add a useful product to 
the global marketplace. 
The utilitarian justification claims that society at large benefits from 
extending exclusive rights to the innovators. That is, we take on the 
cost of granting exclusive rights in exchange for obtaining socially 
useful products created by the inventor. With respect to the Grace 
patent, a utilitarian might argue that the global community benefits 
from extending Grace temporary rights to the stable azadirachtin 
pesticide, for we all now have access to a non-toxic pesticide. The 
utilitarian might point out that Indian farmers also benefit, for they 
too can now use the solution, freeing labor for other pursuits. Further, 
they might argue that India should invest in its own research, for under 
the TRIPS agreement it could thereby secure recognition of innova-
tions created by Indian scientists. 77 In this vein, one expert exhorts, 
"[i] t is in the interest of developing countries to intensify efforts in the 
to realize that in India, neem is not just another plant. Rather, it is a plant with a long history, 
religious significance, and personal meaning for a large number of individuals. 
73 See Ned Hettinger, Patenting Life: Biotechnology, Intellectual Property, and Environmental Eth-
ics, 22 B.C. ENVTL. AFF. L. REv. 267, 278 (1995). See also Moore v. Regents of the Univ. of Cal., 
793 P.2d 479, 479 (Cal. 1990) (elucidating the argument). 
74 U.s. CONST. art. I, § 8, d. 8. 
75 See Diamond v. Chakrabarty, 447 U.S. 303 (1980). 
76 See Moore, 793 P.2d at 479. 
77 See, e.g., Terry & Woessner, supra note 39; Tolan, supra note 16, at 23. 
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application of modern science rather than preventing others from 
doing what they are not doing themselves. "78 
This perspective contrasts sharply with the holistic view of property 
and life expressed by those challenging Grace. In their view, an intel-
lectual property right is only created if the object in toto would not have 
existed but for the individual's investment of labor. A living organism 
has an essential quality which prevents it from ever being considered 
"invented" by someone else. On this basis, even a genetically altered 
organism has morally considerable interests that prevent it from being 
treated as a mere resource that people are naturally entitled to own. 79 
Thus, patent protection of a machine or a method of production 
creates a natural property right in that item, but the manipulation of 
living organisms does not.80 Vandana Shiva claims that the roots of this 
essentialist view lie in the distinctive features of living-systems to self 
organize. She adds that "[s] elf-organizing systems are autonomous and 
self-referential ... [Our aim should be] in keeping the self-organiza-
tion of living systems free-free of technological manipulations that 
destroy the self-healing and self-organizational capacity of organ-
iSIlIS. "81 
At the press conference announcing the neem tree challenge, 
Jeremy Rifkin expressed the global implications of this philosophical 
divide, noting that, "[t]he real battle is whether the genetic resources 
of the planet will be maintained as a shared commons or whether this 
common inheritance will be commercially enclosed and become the 
intellectual property of a few big corporations."82 
This essentialist challenge to intellectual property protection has 
particularly deep roots in India, where religious and cultural traditions 
have infused both flora and fauna with symbolic meanings.83 Indeed, 
within the predominant Hindu religion, most animals and trees as well 
as rivers, lakes and hills, are treated as sacred representations of God. 
The international demand to commodify these entities thus flies in the 
face of these deeply rooted, culturally important traditions. Shiva 
makes the significance of this challenge clear, writing that to recognize 
78 Sharma, supra note 15, at A6, quoting S. Anand Kumar, Professor at SUNY-Albany. 
79 See Hettinger, supra note 73, at 283. 
80 SeeTHE CRUCIBLE GROUP, PEOPLE, PLANTS AND PATENTS 15 (1994); SHIVA, MONOCULTURES, 
supra note 6, at 14-18, 122-25. This idea is developed fully by Hettinger, supra note 73, passim. 
81 SHIVA, BIOPIRACY, supra note 6, at 32-39. 
82 Burns, supra note 31, at D4, quoting Jeremy Rifkin. 
83 SeeTHE CAMBRIDGE ENCYCLOPEDIA OF INDIA 338 (Francis Robinson ed., 1989). 
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patents on life will "undermine [the Indian] cultural and ethical fabric 
[which is] based on agriculture, in which the fundamental life proc-
esses are treated as sacred, not as commodities to be bought and sold 
on the market. "84 Her position has been enshrined in Indian patent 
law which thus far has refused to grant patents on living entities.85 
The neem tree is much more than just a plant in India and to many 
Indians is fundamentally non-commodifiable. Indeed, the tree has 
both religious and cultural significance throughout India. Communi-
ties have invested centuries of care, respect, and knowledge in using 
neem in fields, homes, and for health. If ownership could be claimed, 
the Grace challengers maintain, it would go first to the community 
which nurtured and developed uses for neem trees over the centuries.86 
They insist that in any case, this "ownership" would be non-exclusion-
ary, because ownership of life is fundamentally immoral and contrary 
to tradition. Some maintain that patenting the neem is analogous to 
patenting an egg, or some other symbol of common life, ritual, and 
celebration.87 
The neem challengers also object to the presumption that patent 
protection is necessary for continued innovation.88 They note that in 
India innovation has occurred continually on a local level, with farmers 
and breeders sharing knowledge about qualities and uses of plants, 
animals, and microorganisms.89 Indians point to the fact that "tradi-
tional knowledge" is highly valued by the West as proof that this form 
of innovation has been productive. Activists maintain further that these 
traditional forms of innovation are preferable because they are gener-
ally in tune with local ecology and because they always provide mutual 
benefit and mutual advancement for innovators and users.90 Ultimately, 
an Indian official suggests that industrialized countries would benefit 
by mimicking this tradition. He offers an alternative approach to global 
knowledge production and development: "If the Western scientists and 
multinational [companies] really want to help developing countries 
84 SHlVA, MONOCULTURES, supra note 6, at 122. 
85 See Group Challenges W.R. Grace Pesticide Patent, supra note 36; see also SHIVA, BIOPlRACY, 
supra note 6, at 19-40. 
86 See Reexamination, supra note 61; Burns, supra note 31, at D4. 
87 See Discussion with Kathleen Hiltsley, Program Assistant, Institute for Agriculture and l1rade 
Policy, Minneapolis, Minn. (Mar. 16, 1998). 
88 This presumption has been challenged in international discussions. See THE CRUCIBLE 
GROUP, supra note 80, at 55-60. 
89 See Roht-AlTiaza, supra note 56, at 931-35. 
90 See id. at 934. 
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such as India, they should share their knowledge and shouldn't patent 
material derived from the genetic resources which these countries 
possess."\J] The challenge to the U.S. intellectual property regime is 
clear: the holistic perspective rejects the commodification of life and 
prefers community-based innovation rather than privatized incentives. 
CONCLUSION 
The neem tree controversy is composed of a number of different 
facets. On an instinctive level, many Indians simply distrust any action 
taken by multinational companies. With their history of colonial ex-
ploitation and recent large-scale industrial accidents, Indians tend to 
see multinational companies as the enemy of Indian freedom. 92 More-
over, many Indians are angry at the fact that the multinational compa-
nies seem continually to reap tremendous economic benefits from 
India, while the country as a whole remains very poor. Activist organi-
zations express outrage that Grace can use knowledge that is so com-
monplace in India to achieve million dollar international profits. This 
fact only serves to intensifY the sense that the international intellectual 
property regimes are rigged against developing countries such as India. 
Indians maintain that India suffers net losses at the hands of these 
regimes, not because India lacks innovations, but because most of their 
valuable innovations are classified as "folk" knowledge and are there-
fore excluded from international intellectual property protection. 
At the same time, the Grace challengers express a fundamental 
disagreement with the American philosophy for intellectual property 
protection of life. They reject the idea that these protections are nec-
essary for continued innovation. Instead, they maintain that life cannot 
be commodified and must remain common property. To do otherwise 
would destroy entire cultures and upset ethical norms. Based on their 
own history, they insist that healthy innovation is possible-and 
proven-even without regimented intellectual property systems. 
A number oflessons can be taken from this analysis in order to avoid 
the consequences of ongoing international intellectual property dis-
putes. Most of all, it is important to recognize the complexity of the 
issues. There is no doubt that innovations like the one in the Grace 
91 Sharma, supra note 15, at A6, quoting Ashish Kothari, Professor at the Indian Institute of 
Public Administration. 
92 Union Carbide's Bhopal disaster is perhaps the most prominent of these accidents. The 
incident has not been forgotten in India. See, e.g., Union Carbide: Ten Years After the Disaster, Still 
Dealing with the Fall-Out (visited Mar. 9, 1999) <http://www.Prcent:ral.com/rmjf95bhop.htm> . 
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patent are public goods: reduced reliance on toxic pesticides can 
benefit human health worldwide. At the same time, cultural traditions 
should not be blindly sacrificed in the pursuit of profits. 
Various steps can be taken. The United States-and Western coun-
tries generally-must realize that while developing countries continue 
to perceive the distribution of economic benefits of intellectual prop-
erty protections as skewed, there will be resistance to sharing biological 
resources. To make developing countries willing partners in exploiting 
the promise of biodiversity, we should consider devices for sharing 
benefits. In addition, international intellectual property regimes 
should beware of an overly narrow focus on Western forms of knowl-
edge. Policy makers should carefully consider contentions that the 
prevalent intellectual property laws exclude a variety offorms of know 1-
edge. We are likely to see a much richer exchange of ideas if commu-
nities can benefit from revealing their age-old traditions. Further, if 
individuals or communities in developing nations feel that their knowl-
edge is consistently being "ripped off," they are unlikely to reciprocate 
enforcement of intellectual property laws. Finally, and perhaps most 
importantly, we must explicitly address the philosophical differences 
over the issue of patenting life, as this debate is likely to continue in 
new forms. I would hope that representatives from the United States, 
India, and other interested parties could develop a productive dialog 
about the scope and significance of their very different approaches to 
life. Perhaps they can achieve a compromise in which patent protec-
tions will take hold in some nations, while cultural traditions will 
prevent enforcement in others. 
